PMC:7696151 / 32493-32695 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"910","span":{"begin":170,"end":178},"obj":"Species"},{"id":"963","span":{"begin":105,"end":108},"obj":"Chemical"},{"id":"995","span":{"begin":31,"end":55},"obj":"Disease"},{"id":"996","span":{"begin":179,"end":187},"obj":"Disease"},{"id":"997","span":{"begin":193,"end":201},"obj":"Disease"}],"attributes":[{"id":"A910","pred":"tao:has_database_id","subj":"910","obj":"Tax:9606"},{"id":"A963","pred":"tao:has_database_id","subj":"963","obj":"MESH:D006886"},{"id":"A995","pred":"tao:has_database_id","subj":"995","obj":"MESH:D008133"},{"id":"A996","pred":"tao:has_database_id","subj":"996","obj":"MESH:D007239"},{"id":"A997","pred":"tao:has_database_id","subj":"997","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ECG modification, resulting in QT-interval prolongation, is a characteristic side effect associated with HCQ treatment that has been shown in several clinical studies on patients infected with COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T219","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ECG modification, resulting in QT-interval prolongation, is a characteristic side effect associated with HCQ treatment that has been shown in several clinical studies on patients infected with COVID-19."}